₹63.26
▼ -3.25 -4.89%
18 Jul 2026
BSE Listed
ESM 1Novelix Pharmaceuticals Limited (536565)
Volume: 4,372Avg Vol 1W: 3,794Avg Vol 1M: 6,73652W Range:₹38₹92
Key Ratios
Checked just nowMarket Cap₹97 Cr
Current Price₹63.26
Previous Close₹66.51
High / Low (52w)₹92 / ₹38
Volume4,372
Avg Vol (1W)3,794
Avg Vol (1M)6,736
Stock P/E—
Book Value₹12.51
Dividend Yield0%
ROE-30.18%
ROA-30.18%
Revenue (TTM)—
Revenue Growth—
Profit Margin-49.32%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B5.36
Debt / Equity0.01
50 DMA₹67.16
200 DMA₹58.3
Day change-4.89%
SurveillanceESM 1 (as of 2026-07-18)
Price Chart
₹63.26▲ 34.94% · 1Y
2025-07-182026-07-17
20-day avg volume: 6K shares
Pros
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹-3 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹6 Cr | ₹6 Cr | ₹9 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹9 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-4 Cr | ₹-2 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-4 Cr | ₹-2 Cr |
| EPS | 0.11 | 0.12 | -0.01 | -0.43 | -0.3 | -0.35 | -4.62 | -2.22 |
Balance Sheet
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹13 Cr | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹10 Cr | ₹9 Cr |
| Total Liabilities | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| Equity | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹7 Cr | ₹8 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-1 Cr | ₹2 Cr | ₹-2 Cr | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
| Investing | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr |
| Free Cash Flow | ₹-1 Cr | ₹2 Cr | ₹-2 Cr | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
Shareholding
Promoter 50.57% Institutions 0% Public 49.43%
Efficiency & Working Capital
ROCE-32.5%
Interest Coverage-33
Dividend Payout—
Debtor Days52 d
Inventory Days42 d
Payable Days37 d
Cash Conversion Cycle57 d
Working Capital Days94 d
Shareholding Details
As of 2026-06-30
Promoter50.6%
FII0%
DII0%
Institutions0%
Public49.4%
Promoter Pledge0%
No. of Shareholders3,004
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.6% | 66.6% | 66.6% | 52.7% | 53.3% | 54.8% | 54.8% | 52% | 50.8% | 46.5% | 49.4% | 50.6% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 33.4% | 33.4% | 33.4% | 47.3% | 46.7% | 45.2% | 45.2% | 48% | 49.2% | 53.5% | 50.6% | 49.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,533 | 2,502 | 2,484 | 2,408 | 2,754 | 2,770 | 2,770 | 2,994 | 2,997 | 3,029 | 2,975 | 3,004 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Srinidhi Fine-chemicals Llp | Shareholding of Promoter and Promoter Group | 33.1% | 79,02,000 |
| Vupparapalli Chandrasekhar Reddy | Shareholding of Promoter and Promoter Group | 8.9% | 21,30,733 |
| Mallela Venkatramna Reddy | Public Shareholding | 7.7% | 18,30,000 |
| Sesha Sai Nikhil Chintalapati | Public Shareholding | 4.1% | 9,68,000 |
| Srinivasrao Swetha Kanakapur | Public Shareholding | 3.6% | 8,67,000 |
| Narhari Belide | Shareholding of Promoter and Promoter Group | 3.4% | 8,00,000 |
| Vupparapalli Pavani | Shareholding of Promoter and Promoter Group | 3% | 7,25,000 |
| Panchagnula Venkata Lakshmi Narayana Sankara Vara Prasad | Public Shareholding | 2.6% | 6,25,000 |
| Palakurthi Rakesh | Public Shareholding | 2.4% | 5,74,125 |
| Gattu Gnana Prakash | Shareholding of Promoter and Promoter Group | 1.7% | 4,00,000 |
| Soura Investments Holdings Private Limited | Public Shareholding | 1.1% | 2,70,000 |
| Dm Fincon Services Llp | Public Shareholding | 1.1% | 2,50,000 |
| Arati Gattu | Shareholding of Promoter and Promoter Group | 0.4% | 1,00,000 |
| Shyam Agarwal (huf) | Shareholding of Promoter and Promoter Group | 0.1% | 25,000 |
| Neha Gattu | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Vupparapalli Chandrasekhar Reddy | 0 | 0% | 2026-06-07 |
| Vupparapalli Pavani | 0 | 0% | 2026-06-07 |
| Gattu Gnana Prakash | 0 | 0% | 2026-06-07 |
| Narhari Belide | 0 | 0% | 2026-06-07 |
| Shyam Agarwal (huf) | 0 | 0% | 2026-06-07 |
| Arati Gattu | 0 | 0% | 2026-06-07 |
| Neha Gattu | 0 | 0% | 2026-06-07 |
| Srinidhi Fine-chemicals Llp | 0 | 0% | 2026-06-07 |
| Panchagnula Venkata Lakshmi Narayana Sankara Vara Prasad | 0 | 0% | 2026-06-07 |
| Sesha Sai Nikhil Chintalapati | 0 | 0% | 2026-06-07 |
| Srinivasrao Swetha Kanakapur | 0 | 0% | 2026-06-07 |
| Mallela Venkatramna Reddy | 0 | 0% | 2026-06-07 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| VENKATESHWARLU PULLURU | E D & Wholetime Director | 2025 |
| JANARDHAN DAS KABRA | Independent Non Exe. Director | 2025 |
| Jivamohan Divakar Valluri | Non-Exec & Non-Independent Dir | 2025 |
| Monam Kapoor | Independent Non Exe. Director | 2025 |
| Lakshman Samala | Independent Non Exe. Director | 2025 |
| GNANA PRAKASH GATTU | Non-Exec & Non-Independent Dir | 2025 |
| Mayuri Baidya | Independent Non Exe. Director | 2025 |
| Nishita Kalantri | Company Sec. & Compli. Officer | 2025 |
| Sridevi Belide | Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharma Business | ₹0 Cr | 3.2% |
| Financial Activity | ₹0 Cr | 4.5% |
| Investment Activity | ₹0 Cr | 1.5% |
| Trading in Shares | ₹4 Cr | 90.8% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 20 | 10 | 10 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
6 disclosure(s)
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment24/12/2025 · 4,92,000
Pref. Allotment24/06/2025 · 15,00,000
Pref. Allotment11/06/2024 · 15,50,000
Company Information
🌐 www.trimurthidrugs.com ↗
📍 4-4-231/1/2/ABC Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Money Masters Leasing & FAlacrity Securities Ltd.GCM Commodity & DerivativJulien Agro Infratech LimitedJK Agri Genetics Ltd.Future Lifestyle FashionsPVV Infra LimitedVCU Data Management Ltd.IND Renewable Energy Ltd.SRG Fingrow Finance LimitedAmrapali Capital And FinaStellar Capital ServicesAll “53” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search